Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications
Authors:
- Rick M. FairhurstRFRick M. Fairhurst
- Gaurvika M. L. NayyarGNGaurvika M. L. Nayyar
- Joel G. BremanJBJoel G. Breman
- Rachel HallettRHRachel Hallett
- Jonathan L. VennerstromJVJonathan L. Vennerstrom
- Socheat DuongSDSocheat Duong
- Pascal RingwaldPRPascal Ringwald
- Thomas E. WellemsTWThomas E. Wellems
- Christopher V. PloweCPChristopher V. Plowe
- Arjen M. DondorpADArjen M. Dondorp
Open Access
- 1 August 2012
- journal article
- review article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 87 (2) , 231-241
Abstract
Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment of malaria. Recognizing the significance and immediacy of this possibility, the Fogarty International Center and the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health convened a conference in November 2010 to bring together the diverse array of stakeholders responding to the growing threat of artemisinin resistance, including scientists from malarious countries in peril. This conference encouraged and enabled experts to share their recent unpublished data from studies that may improve our understanding of artemisinin resistance. Conference sessions addressed research priorities to forestall artemisinin resistance and fostered collaborations between field- and laboratory-based researchers and international programs, with the aim of translating new scientific evidence into public health solutions. Inspired by this conference, this review summarizes novel findings and perspectives on artemisinin resistance, approaches for translating research data into relevant public health information, and opportunities for interdisciplinary collaboration to combat artemisinin resistance.Keywords
This publication has 74 references indexed in Scilit:
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- Artemisinin activity againstPlasmodium falciparumrequires hemoglobin uptake and digestionProceedings of the National Academy of Sciences, 2011
- Intrahost modeling of artemisinin resistance in Plasmodium falciparumProceedings of the National Academy of Sciences, 2010
- Artemisinin‐Induced Dormancy inPlasmodium falciparum: Duration, Recovery Rates, and Implications in Treatment FailureThe Journal of Infectious Diseases, 2010
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugsNature Genetics, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependentBiochemical Pharmacology, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003